Mumbai, India

Sheerang Vidhyadhar Joshi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Sheerang Vidhyadhar Joshi: Innovator in Fungal Infection Treatment**

Introduction

Sheerang Vidhyadhar Joshi is a notable inventor based in Mumbai, India. He has made significant contributions in the field of pharmaceutical innovation, particularly in developing novel compounds for medical treatments.

Latest Patents

Sheerang holds one patent that highlights his research and innovation. The patent describes novel compounds represented by the Formula (1), which contain thieno-[2,3-d]pyrimidin-4(3H)-one moieties and their pharmaceutically acceptable salts. This invention presents methods for preparing these compounds and explores their application in the prevention and treatment of fungal infections. Additionally, it covers pharmaceutical preparations formulated with these innovative compounds.

Career Highlights

Currently, Sheerang Vidhyadhar Joshi is associated with FDC Limited, a company focused on delivering high-quality pharmaceutical products. His role at FDC Limited allows him to bring his inventive ideas and research into practice, contributing to the company's mission of improving health outcomes through innovation.

Collaborations

Throughout his career, Sheerang has worked alongside notable colleagues, including Hanumant Bapurao Borate and Suleman Riyajsaheb Maujan. Their collaboration reflects a collective effort to enhance pharmaceutical research and development, further driving innovation in the field.

Conclusion

In conclusion, Sheerang Vidhyadhar Joshi's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for compounds effective against fungal infections is a testament to his dedication to enhancing healthcare. As he continues his journey at FDC Limited, the impact of his inventions will undoubtedly be felt in the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…